Remarkably, expression of HLA‐A, HLA‐B, and HLA‐C was significantly lower in NEC‐GYN compared to ovarian and cervical cancer (P‐value < 0.0001), further corroborating immunosuppressive nature of NEC‐GYN (Fig. S17). This evidence concerns the gene HLA-B and neuroendocrine carcinoma.